Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TBN for Type 2 Diabetic Nephropathy (Phase 2)
ChiCTR2100043019Phase 2Recruiting
- Sponsor
- Shanghai Sixth People's Hospital
- Start
- Mar 2021
- Modality
- Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised trial of tetramethylpyrazine nitrone in diabetic glomerulosclerosis (3 arms), sponsored by Shanghai Sixth People's Hospital. Primary endpoint: Urinary albumin-to-creatinine ratio (UACR). Started Mar 2021; status: recruiting.
02
Drugs
tetramethylpyrazine nitrone
03
Conditions
diabetic glomerulosclerosis
Beyond the preview
Go deeper on ChiCTR2100043019.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2100043019.